Feature

Research Reports

Barriers to Lymphoma Clinical Practice Guideline Adherence: A Pilot Mixed-Methods Research Study

04/16/2019

Abstract: Little is published about adherence barriers to lymphoma clinical practice guidelines (CPGs). This article examines the most frequent barriers to adherence to lymphoma CPGs. An explanatory sequential...

...

04/16/2019

Journal of Clinical Pathways

Case Study

Patient-Reported Outcomes: Investing in Real-Time Intervention to Improve Care

04/16/2019

Diane Denny , DBA, MHA, FACHE, CPHQ, CPPS;

Brandon Bosch , MPH;

Scott R. Hartman , MS, PMP;

Morgan Hannaford , MA;

Abstract: A geographically dispersed network of hospitals began the journey to integrate patient-reported outcome (PRO) data in the form of quality-of-life measurement into daily operations beginning in 2012, moving...

...

04/16/2019

Journal of Clinical Pathways

Research Reports

Impact of Psychosocial Factors on Health Services Utilization and Cost of Care in Blood and Marrow Transplant Patients

03/13/2019

Chenguang Zhang , MS;

Yordanka N. Koleva , PhD;

Jerrold Yeo , PsyD;

Lisa C. Solursh-Abbrecht , PsyD;

Nakhle Saba , MD;

Hana Safah , MD;

Abstract: Hematopoietic stem cell transplant (HSCT) for blood and bone marrow disorders is a costly procedure that requires complex treatment regimens. In addition to disease-related factors, comorbidity and...

...

03/13/2019

Journal of Clinical Pathways

Perspectives

Advocating for New Patient-Centered Tools for Value-Based Treatment Choices in Oncology

03/13/2019

Henry A. Glick , PhD;

Jalpa A. Doshi , PhD;

Ellen Miller-Sonet , MBA, JD;

Justin T. Puckett ;

Abstract: The cost of medical drugs continues to increase, and costs of novel therapies for oncology are particularly expensive—for patients as well as health systems in general. Many health care stakeholders are...

...

03/13/2019

Journal of Clinical Pathways

Research Reports

Resource Utilization and Expenditures During the “Watchful Waiting” Period in Patients With Recurrent Ovarian Cancer

02/19/2019

Karin Travers , DSc;

Adrienne M. Gilligan , PhD;

Paula Smith , MS;

Paul Juneau , MS;

Mohan Bala , PhD;

Brian M. Davis , PhD;

Brooke Harrow , PhD;

Abstract: This article aims to quantify the use of health services during the watchful waiting period after second-line platinum-based therapy among patients with ovarian cancer. Women newly diagnosed with ovarian,...

...

02/19/2019

Journal of Clinical Pathways

Perspectives

Getting “Bundle Ready”: How Provider Organizations Can Design Clinical Pathways in the Context of Bundled Payments

02/19/2019

Joshua M. Liao , MD, MSc, FACP;

Christopher P. Chen , MD, MBA;

Abstract: Clinical pathways can be meaningful tools for improving the quality and value of care. Pathway initiatives are also influenced by payment policy, taking different forms and adopting different emphases...

...

02/19/2019

Journal of Clinical Pathways

Research Reports

The Oncology Care Model Performance Period 2 Results: Practices Are Making Some Progress, But Major Challenges Remain

12/13/2018

Charles Saunders , MD;

Abstract: When launched in 2016, the Oncology Care Model (OCM) represented one of the most advanced efforts yet to migrate health care delivery from fee-for-service to fee-for-value. Practices representing nearly...

...

12/13/2018

Journal of Clinical Pathways

Perspectives

Bundled Payments: A Rising Tide for Clinical Pathways

12/13/2018

Joshua M. Liao , MD, MSc, FACP;

Abstract: As a value-based payment model, bundled payments represent a key component of the ongoing nationwide shift toward value-based care. The Centers for Medicare & Medicaid Services (CMS) has led the...

...

12/13/2018

Journal of Clinical Pathways

Research Reports

Cancer Patient Perspectives on the Use of Clinical Pathways and Shared Decision-Making in Cancer Care

11/18/2018

Linda House , MSM, BSN, RN;

Elizabeth F. Franklin , MSW, LGSW, ACSW;

Shauna McManus , BS;

Helen M. Nichols , PhD, MSW;

Ellyn Charap , MS;

Joanne S. Buzaglo , PhD;

Abstract: The United States has one of the most expensive heath care systems in the world, and the costs of cancer care are rising faster than costs in other medical fields. Value-based care is being implemented in...

...

11/18/2018

Journal of Clinical Pathways

Perspectives

Lessons From Effective Value-Based Care Models in Hematopoietic Stem Cell Transplantation

11/16/2018

James Gajewski , MD, MACP;

Abstract: Patient-centered medical homes (PCMHs) have been designed to offer coordinated care delivery across the entire spectrum of care, aiming to provide optimal care for patients given their individual...

...

11/16/2018

Journal of Clinical Pathways

Current Issue

October 2024

Volume 10

Issue 5

Current Issue

Issue Archive

Special Reports

Sponsored

JCP Special Report

The Value of Tissue-Based Genomic Profiling in Oncology

09/17/2024

Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.

Innovations in precision...

09/17/2024

Journal of Clinical Pathways

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee ;

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Robin T. Zon , MD, FACP, FASCO;

Gordon Kuntz ;

Winston Wong , PharmD;

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan ;

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Feature

Current Issue

Special Reports

Subscribe

Specialties

Events

Year Round Education

HMP Global Products